Public Sector Pension Investment Board (PSP Investments)’s Revance Therapeutics, Inc. RVNC Stock Holding History

Public Sector Pension Investment Board (PSP Investments)’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-42,000	Closed	-$207K	–	1258
2024 Q1	$207K	Hold	42,000	–	–	﹤0.01%	1220
2023 Q4	$369K	Sell	42,000 -134,000	-76%	-$1.1M	﹤0.01%	1183
2023 Q3	$2.02M	Sell	176,000 -78,000	-31%	-$1.5M	0.01%	763
2023 Q2	$6.43M	Hold	254,000	–	–	0.04%	306
2023 Q1	$8.18M	Buy	254,000 +120,000	+90%	+$3.74M	0.06%	247
2022 Q4	$2.47M	Buy	+134,000	New	+$3.07M	0.02%	797
2021 Q4	–	Sell	-49,000	Closed	-$1.36M	–	1488
2021 Q3	$1.36M	Buy	+49,000	New	+$1.4M	0.01%	1254

Other funds holding RVNC

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Public Sector Pension Investment Board (PSP Investments)'s RVNC Position: Q2 2024 in Review

Public Sector Pension Investment Board (PSP Investments) sold out of Revance Therapeutics, Inc. (RVNC) in Q2 2024, closing a stake of 42,000 shares — an estimated $207K sold.

Public Sector Pension Investment Board (PSP Investments) first reported a position in RVNC in Q3 2021 and held it in 7 quarters. The position peaked at $8.18M in Q1 2023. 173 funds tracked by Wall St. Rank hold RVNC as of Q2 2024.

Public Sector Pension Investment Board (PSP Investments) reported no remaining Revance Therapeutics, Inc. position as of Q2 2024 after selling out during the quarter.
Public Sector Pension Investment Board (PSP Investments) sold 42,000 Revance Therapeutics, Inc. shares in Q2 2024, an estimated $207K.
Public Sector Pension Investment Board (PSP Investments) first reported a position in Revance Therapeutics, Inc. in Q3 2021 and held it in 7 quarters.
Public Sector Pension Investment Board (PSP Investments)'s Revance Therapeutics, Inc. position peaked at $8.18M in Q1 2023.
173 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q2 2024.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q2 2024, filed 14 Aug 2024.